In an MRL-Fas(lpr) lupus murine model, blocking the IL-21 signal with an IL-21R.Fc fusion protein reduced the phenotypic disease severity, such as proteinuria, skin lesions, as well as renal injury and autoantibody production [71,72]. Here, IL21R is linked to systemic lupus erythematosus.